Wegovy Weight Loss Injection UK Private Prescription £79.00
Cheapest Wegovy Private Prescription - UK Price £69
Get Wegovy weight loss injection at the cheapest UK price from £69 with £20 off your first order using code WEIGHTLOSSNEW.
Takes less than 2 minutes to complete 100% online
Treatment from £69
Check if you're eligible
Your BMI
26.8ⓘ Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.
Our Pricing
Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.
2.5mg
1 pen • 4 Weeks
£31.25 / Per Week
Your starting dose – designed to help your body adjust gently to treatment
5mg
1 pen • 4 Weeks
£39.75 / Per Week
First step up – builds on your progress as your body adapts to treatment
7.5mg
1 pen • 4 Weeks
£50.00 / Per Week
Mid-range dose – for continued progression and enhanced results
10mg
1 pen • 4 Weeks
£56.25 / Per Week
Higher strength dose – supports significant weight loss progress
12.5mg
1 pen • 4 Weeks
£62.50 / Per Week
Advanced dose – for patients requiring stronger therapeutic effect
15mg
1 pen • 4 Weeks
£66.75 / Per Week
Maximum dose – the highest available strength for optimal results
0.25mg
1 pen • 4 Weeks
£17.25 / Per Week
Your starting dose – eases your body into treatment with minimal side effects
0.5mg
1 pen • 4 Weeks
£19.75 / Per Week
First step up – continues building tolerance for long-term success
1mg
1 pen • 4 Weeks
£24.75 / Per Week
Mid-range dose – where most patients start seeing meaningful results
1.7mg
1 pen • 4 Weeks
£37.25 / Per Week
Higher strength – supports accelerated weight loss progress
2.4mg
1 pen • 4 Weeks
£44.75 / Per Week
Maximum dose – the highest available strength for optimal weight management
1.5mg
1 pen • 4 Weeks
£20.75 / Per Week
Your starting dose – eases your body into treatment with minimal side effects
4mg
1 pen • 4 Weeks
£27.50 / Per Week
First step up – continues building tolerance for long-term success
9mg
1 pen • 4 Weeks
£35.00 / Per Week
Mid-range dose – where most patients start seeing meaningful results
25mg
1 pen • 4 Weeks
£49.75 / Per Week
Maximum dose – the highest available strength for optimal weight management
Published on: June 03, 2026
Seeking a wegovy weight loss injection uk private prescription with transparent pricing and expert clinical support? Cured Pharmacy offers genuine UK-licensed Wegovy from £79.00, with free online consultations completed in under 3 minutes by our UK-registered clinical team. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription meets MHRA standards for safety and efficacy.
How Wegovy Semaglutide Injections Work for Weight Loss
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics natural hormones your body produces after eating [1]. By activating GLP-1 receptors in the brain, pancreas, and digestive system, semaglutide reduces appetite, slows gastric emptying, and improves blood sugar regulation — creating the metabolic conditions that support sustainable weight reduction.
In the landmark STEP 1 clinical trial, participants using Wegovy alongside lifestyle modifications achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [1]. These results led to MHRA approval in 2021 and subsequent NICE guidance recommending semaglutide for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity [2].
Unlike oral appetite suppressants, Wegovy's once-weekly subcutaneous injection delivers consistent therapeutic levels throughout the week. The gradual dose escalation protocol — starting at 0.25mg and increasing to a maintenance dose of 2.4mg over 16-20 weeks — minimises gastrointestinal side effects whilst optimising weight loss outcomes [3].
Wegovy Injection UK Price and What's Included
Every Wegovy prescription at Cured Pharmacy includes a comprehensive clinical assessment by a UK-registered prescriber. Your clinician reviews your medical history, current medications, BMI calculation, and weight loss goals to determine whether Wegovy is clinically appropriate and which dosing schedule suits your individual needs.
Our GPhC-registered pharmacy (9012511) dispenses only genuine UK-licensed Wegovy manufactured by Novo Nordisk. Each pen arrives in original packaging with patient information leaflets, stored and transported under temperature-controlled conditions to maintain medication integrity. We use 100% discreet packaging — no pharmacy branding or treatment details visible on the outer parcel.
Transparent Pricing Before Your Consultation
At Cured Pharmacy, you see the exact price before completing your free clinical assessment. Our wegovy weight loss injection uk private prescription service starts from £79.00, with no hidden consultation fees or surprise charges at checkout. This price includes your UK prescriber review, genuine MHRA-licensed Wegovy pen, and discreet home delivery.
We guarantee the lowest prices in the UK. If you find a lower advertised price from another registered UK pharmacy for the same Wegovy dose, we'll match it. Our transparent pricing model means you can budget confidently for your weight management programme without navigating complex tiered pricing structures or membership schemes.
Who Can Use Wegovy Weight Loss Injections
Clinical trials excluded patients under 18 years, so Wegovy is licensed only for adult use in the UK. If you have a history of pancreatitis, diabetic retinopathy, or renal impairment, your prescriber will carefully evaluate the risk-benefit profile before recommending treatment.
Successful weight loss with Wegovy requires commitment to lifestyle modifications alongside medication. The STEP trials combined semaglutide with reduced-calorie diet and increased physical activity, demonstrating that pharmacotherapy works best as part of a comprehensive weight management programme [1]. Your prescriber may recommend nutritional counselling or structured exercise plans to optimise your outcomes.
Clinical Eligibility Criteria
NICE guidelines recommend semaglutide 2.4mg for adults with an initial BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease [2]. Your UK prescriber will calculate your BMI during the online consultation and assess your medical suitability.
Wegovy is not suitable during pregnancy or breastfeeding, for patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, or those with severe gastrointestinal disease [3]. Your clinical assessment will identify any contraindications before a prescription is issued.
Wegovy Dosing Schedule and Administration
Wegovy follows a structured dose escalation protocol designed to improve gastrointestinal tolerability whilst reaching the therapeutic 2.4mg maintenance dose. You begin with 0.25mg once weekly for four weeks, then increase to 0.5mg for four weeks, 1mg for four weeks, 1.7mg for four weeks, and finally 2.4mg as your ongoing maintenance dose [3].
Each pre-filled pen delivers a single subcutaneous injection into your abdomen, thigh, or upper arm. You choose the same day each week for your injection — many patients find Sunday evenings convenient to establish a consistent routine. The pen design requires no dose measurement or needle attachment, making self-administration straightforward even for injection-naïve patients.
If you miss a dose and it's been less than five days, inject as soon as you remember. If more than five days have passed, skip that dose and resume your regular schedule. Never double up doses to compensate for missed injections. If you experience persistent nausea or vomiting that prevents you from tolerating dose increases, your prescriber may extend the time at your current dose before escalating further [3].
Expected Results and Clinical Outcomes with Wegovy
Beyond the number on the scale, clinical trials demonstrated improvements in cardiometabolic risk factors including reductions in waist circumference, blood pressure, HbA1c in patients with prediabetes, and inflammatory markers [1]. Many patients report enhanced mobility, reduced joint pain, improved sleep quality, and better psychological wellbeing as weight decreases.
Wegovy is intended for chronic weight management, not short-term use. Discontinuing treatment often leads to weight regain, as observed in STEP 4 where participants who switched from semaglutide to placebo regained approximately two-thirds of their lost weight over 48 weeks [4]. Your prescriber will discuss long-term treatment strategies and how to maintain results if you eventually discontinue Wegovy.
Timeline for Weight Loss
Most patients notice reduced appetite and early weight loss within the first 4-8 weeks of starting Wegovy, even at the lower initial doses. However, maximal weight reduction typically occurs after reaching the 2.4mg maintenance dose and continuing treatment for several months. In STEP 1, participants achieved approximately 5% weight loss by week 20, 10% by week 40, and peak reductions around week 60-68 [1].
Individual results vary based on baseline BMI, adherence to lifestyle modifications, metabolic factors, and concurrent medications. Your prescriber will monitor your progress and may recommend continuing treatment if you achieve at least 5% weight loss after 12 weeks at the maintenance dose, in line with NICE guidance [2].
Wegovy Side Effects and Safety Considerations
In animal studies, semaglutide caused thyroid C-cell tumours at exposures similar to human therapeutic doses, though no cases of medullary thyroid carcinoma have been confirmed in human trials [3]. As a precaution, Wegovy is contraindicated in patients with personal or family history of this rare cancer type.
Your prescriber will review your complete medication list during consultation, as Wegovy can delay gastric emptying and potentially affect absorption of oral medications. If you take oral contraceptives, levothyroxine, or medications with narrow therapeutic windows, your clinician may recommend specific timing strategies to maintain therapeutic efficacy [3].
Common and Serious Adverse Effects
The most frequently reported side effects are gastrointestinal: nausea (44% of participants in STEP 1), diarrhoea (30%), vomiting (24%), constipation (24%), and abdominal pain (20%) [1]. These effects are typically mild to moderate, most common during dose escalation, and diminish over time as your body adapts to semaglutide. Eating smaller portions, avoiding high-fat meals, and staying well-hydrated can help manage these symptoms.
Serious but rare adverse events include pancreatitis, gallbladder disease, acute kidney injury (usually secondary to dehydration from vomiting/diarrhoea), and hypoglycaemia when used with insulin or sulfonylureas [3]. Contact your GP or NHS 111 immediately if you experience severe persistent abdominal pain, signs of pancreatitis, or symptoms of dehydration.
Scientific References
- Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
- National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
- Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
- Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
- NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
- NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
- NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.
Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary. Weight loss outcomes depend on multiple factors including adherence to lifestyle modifications, baseline BMI, and individual metabolic response.
Trusted by thousands
Real people, real results
Jane L.
"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."
Ann-Marie
"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."
Sacha W.
"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."
Kimberly G.
"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"
Jennifer
"Great really helps cure those nasty habits can't wait for my next mounjaro pen."
How it Works?
Start Your Assessment For Weight Loss
Start your journey to better health today.
- Reviewed by UK-based prescribers
- Takes under 3 minutes
- Discreet Packaging
Start Your Journey To Better Health Today
Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.
Start My Assessment Log in to Your AccountFaq
Medically reviewed by
Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)
Reviewed on: June 03, 2026